Stock Price
25.17
Daily Change
0.51 2.07%
Monthly
-1.68%
Yearly
8.73%
Q1 Forecast
23.84

Celldex Therapeutics reported $66.45M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Amgen USD 538M 300K Sep/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Celldex Therapeutics USD 66.45M 53K Sep/2025
Glaxosmithkline GBP 4.03B 2.68B Sep/2025
Pfizer USD 5.69B 1000K Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025